Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.413NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.268NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.409NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.587NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-20190.6US
B.1.232NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.5.2.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CD.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
BQ.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used